A novel synthesis of rasagiline via a chemoenzymatic dynamic kinetic resolution

Organic Process Research and Development

Volumn 18, Issue 10, 2014, Pages 1169-1174

  Ma, Guozhen ^a   Xu, Zhongqi ^a   Zhang, Pengfei ^a   Liu, Jinpo ^a   Hao, Xilin ^a   Ouyang, Jingping ^a   Liang, Ping ^a   You, Song ^a   Jia, Xian ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIC KINETIC RESOLUTION; RASAGILINE;

EID: 84908067143     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op500152g     Document Type: Article

References (28)

1. Breuer, M.; Ditrich, K.; Habicher, T.; Hauer, B.; Keßeler, M.; Stürmer, R.; Zelinski, T. Industrial Methods for the Production of Optically Active Intermediates. Angew. Chem., Int. Ed. 2004, 43 (7), 788-824.
2. Träff, A.; Lihammar, R.; Bäckvall, J.-E. A Chemoenzymatic Dynamic Kinetic Resolution Approach to Enantiomerically Pure (R)- and (S)-Duloxetine. J. Org. Chem. 2011, 76 (10), 3917-3921.
3. Truppo, M. D.; Hughes, G. Development of an Improved Immobilized CAL-B for the Enzymatic Resolution of a Key Intermediate to Odanacatib. Org. Process Res. Dev. 2011, 15 (5), 1033-1035.
4. Pesti, J. A.; Yin, J.; Zhang, L.-h.; Anzalone, L.; Waltermire, R. E.; Ma, P.; Gorko, E.; Confalone, P. N.; Fortunak, J.; Silverman, C.; Blackwell, J.; Chung, J. C.; Hrytsak, M. D.; Cooke, M.; Powell, L.; Ray, C. Efficient Preparation of a Key Intermediate in the Synthesis of Roxifiban by Enzymatic Dynamic Kinetic Resolution on Large Scale. Org. Process Res. Dev. 2003, 8 (1), 22-27.
5. Hu, L.; Schaufelberger, F.; Zhang, Y.; Ramstrom, O. Efficient asymmetric synthesis of lamivudine via enzymatic dynamic kinetic resolution. Chem. Commun. 2013, 49 (88), 10376-10378.
6. (a) Hoy, S.; Keating, G. Rasagiline. Drugs 2012, 72 (5), 643-669.
7. (b) Perez-Lloret, S.; Rascol, O. Safety of rasagiline for the treatment of Parkinson's disease. Expert Opin. Drug Safety 2011, 10 (4), 633-643.
8. (c) Weinreb, O.; Amit, T.; Riederer, P.; Youdim, M. B. H.; Mandel, S. A., Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease. In International Review of Neurobiology; Moussa, B. H. Y., Peter, D., Eds.; Academic Press: New York, 2011; Vol. 100, pp 127-149.
9. (a) Chen, T. T.; Yao, C. H. Method for producing compound for preparation of anti-parkinson's disease drug. US2011218361A1, 2011.
10. (b) Thanedar, A. A.; Deshmukh, S. A.; Zope, S. S.; Kelkar, L. M.; Koilpillai, J. P.; Gajera, J. M. Processes for the preparation of propargylated aminoindans or a pharmaceutically acceptable salt thereof. WO2011048612A2, 2011.
11. (c) Cherukupally, P.; Vajrala, V. R.; Adla, V. K.; Rangineni, S.; Kanniah, S. Preparation of rasagiline and salts thereof. WO 2010059913A2, 2010.
12. (d) Allegrini, P.; Romano, B. G.; Attolino, E.; Artico, M.; Rossi, D. Crystalline Form of Rasagiline and Process for the Preparation Thereof. US2010029987A1, 2010.
13. (e) Goel, O. P. Improved process for the resolution of 1-aminoindanes. EP0235590A2, 1987.
14. (f) Berger-Paskin, T.; Finberg, J. P. M.; Lerner, D.; Levy, R.; Sterling, J.; Veinberg, A.; Yellin, H.; Youdim, M. B. H. R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof. WO9511016, 1995.
15. (g) Youdim, M. B. H.; Finberg, J. P. M.; Levy, R.; Sterling, J.; Lerner, D.; Berger-Paskin, T.; Yellin, H. R-Enantiomer of N-propargyl-1-aminoindan, its preparation and pharmaceutical compositions containing it. EP0436492, 1994.
16. (h) Feng, Q. Simple and novel process for preparing indenes derivatives. CN1990455A1, 2007.
17. (i) Gutman, A. L.; Nisnevich, G.; Ponomarev, V.; Sotrihin, M.; Zaltzman, I. Process for the preparation of rasagiline and its salts. WO2002068376 A1, 2002.
18. (a) Colyer, J. T.; Andersen, N. G.; Tedrow, J. S.; Soukup, T. S.; Faul, M. M. Reversal of Diastereofacial Selectivity in Hydride Reductions of N-tert-Butanesulfinyl Imines. J. Org. Chem. 2006, 71 (18), 6859-6862.
19. (b) Uiterweerd, P. G. H.; van der Sluis, M.; Kaptein,B.; de Lange, B.; Kellogg, R. M.; Broxterman, Q. B. (S)-1-Aminoindane: synthesis by chirality transfer using (R)-phenylglycine amide as chiral auxiliary. Tetrahedron: Asymmetry 2003, 14 (22), 3479-3485.
20. (c) Pakulski, M. M.; Mahato, S. K.; Bosiak, M. J.; Krzeminski, M. P.; Zaidlewicz, M. Enantioselective reduction of ketoxime ethers with borane-oxazaborolidines and synthesis of the key intermediate leading to (S)-rivastigmine. Tetrahedron: Asymmetry 2012, 23 (9), 716-721.
21. Kim, Y.; Park, J.; Kim, M.-J. Fast racemization and dynamic kinetic resolution of primary benzyl amines. Tetrahedron Lett. 2010, 51 (42), 5581-5584.
22. (a) Paetzold, J.; Bäckvall, J. E. Chemoenzymatic Dynamic Kinetic Resolution of Primary Amines. J. Am. Chem. Soc. 2005, 127 (50), 17620-17621.
23. (b) Reetz, M. T.; Schimossek, K. Lipase-Catalyzed Dynamic Kinetic Resolution of Chiral Amines: Use of Palladium as the Racemization Catalyst. CHIMIA Int. J. Chem. 1996, 50 (12), 668-669.
24. Qin, B.; Liang, P.; Jia, X.; Zhang, X.; Mu, M.; Wang, X.-Y.; Ma, G.- Z.; Jin, D.-N.; You, S. Directed evolution of Candida antarctica lipase B for kinetic resolution of Profen esters. Catal. Commun. 2013, 38 (0), 1-5.
25. Thalén, L. K.; Bäckvall, J.-E. Development of dynamic kinetic resolution on large scale for (±)-1-phenylethylamine. Beilstein J. Org. Chem. 2010, 6, 823-829.
26. Lee, J. H.; Han, K.; Kim, M.-J.; Park, J. Chemoenzymatic Dynamic Kinetic Resolution of Alcohols and Amines. Eur. J. Org. Chem. 2010, 2010 (6), 987-987.
27. Duward F. Shriver, M. A. D. The Manipulation of Air-Sensitive Compounds, 2nd ed.; John Wiley & Sons, Inc.: New York, 1986.
28. Sathe, D. G. Process for preparation of rasagiline and salts thereof. EP2364967A2, 2011.